Corrections to “Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors”
Titel:
Corrections to “Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors”
Auteur:
Soria, J.-C. Cortes, J. Massard, C. Armand, J.-P. De Andreis, D. Ropert, S. Lopez, E. Catteau, A. James, J. Marier, J.-F. Beliveau, M. Martell, R.E. Baselga, J.